Company Filing History:
10 out of 1,309 
1 out of 71 
Years Active: 2003-2009
Title: The Innovative Mind of David LeRoy Crandall
Introduction
David LeRoy Crandall is an accomplished inventor based in Doylestown, Pennsylvania. With a remarkable portfolio of 10 patents, he has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit plasminogen activator inhibitor type-1 (PAI-1). His work not only reflects his inventive spirit but also serves as a foundation for future advancements in medicine.
Latest Patents
Among David's latest innovations is his patent for "Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)". This patent presents PAI-1 inhibiting compounds represented by a complex formula that includes various substituents, offering potential avenues for therapeutic applications. Another notable patent is focused on "Biphenyloxy-acids," which relates to substituted biphenyloxy acids, including structures like 4'-aryl-amido-biphenyl-4(3)-yloxy-acids. These compounds and their methods of usage as PAI-1 inhibitors underscore David's role in advancing pharmacological science.
Career Highlights
David has built his career within reputable organizations, including Wyeth and American National Red Cross. His experience in these companies has equipped him with the knowledge and skills necessary to excel in innovative research and development, particularly in the pharmaceutical sector. His contributions to these firms have been pivotal, leveraging cutting-edge research to propel medical science forward.
Collaborations
Throughout his career, David has had the opportunity to collaborate with talented individuals, including fellow researchers Hassan Mahmoud Elokdah and Scott Christian Mayer. These collaborations have likely enriched his work, fostering a dynamic exchange of ideas and creativity that drives innovation in his projects.
Conclusion
David LeRoy Crandall continues to be a significant figure in the world of invention and innovation. With a strong focus on developing new pharmaceutical agents, his contributions in the form of patents reflect a commitment to bettering human health. As research progresses, it is anticipated that his work will pave the way for future breakthroughs in treating diseases linked to PAI-1 and beyond.